EDINA, Minn., Oct. 28, 2011 /PRNewswire/ -- ARKRAY USA, Inc. (ARKRAY) announced today that the GLUCOCARD® Vital and 01 are now listed on the Department of Defense (DoD) Uniform Formulary. The DoD Pharmacy and Therapeutic committee (P&T) selected both the GLUCOCARD® Vital and the GLUCOCARD® 01 Blood Glucose Meters as the first and second most cost effective blood glucose meters in all points of service as noted by the Uniform Formulary Beneficiary Advisory Panel (BAP) earlier this year.

Both GLUCOCARD Vital and GLUCOCARD 01 meter systems feature advanced auto coding technology and require only a tiny sample size at a cost that is less than other blood glucose meter systems on the Uniform Formulary including the current blood glucose meter offered on the Basic Core Formulary.

"We're excited that ARKRAY has two meters on the Department of Defense Uniform Formulary," said Jonathan Chapman, President of ARKRAY. "Our GLUCOCARD meter systems offer high performance standards. To be recognized by the DoD for having the most cost-effective blood glucose meters is an honor."

ARKRAY will be demonstrating their GLUCOCARD Blood Glucose Meters at the Joint Forces Pharmacy Seminar (JFPS) in Dallas, TX next week. "Exhibiting at the largest annual event for the military pharmacy community is the perfect opportunity to show pharmacists and technicians first hand how our products perform for their patients with diabetes," said Robert Wernsman, Vice President of Consumer Healthcare Division.

About ARKRAY

ARKRAY has been a pioneer for over 50 years in the field of automated analysis from laboratory and point-of-care systems to home use patient self testing systems. ARKRAY invests heavily in R&D and has a strong commitment to high-quality products. ARKRAY is the company that developed the world's commercially successful portable blood glucose analyzer in the early 1970s and the world's first A1C analyzer in 1982.

(Date:12/8/2016)... , Dec. 8, 2016 Eli Lilly and ... results of its phase 3 EXPEDITION3 trial at the ... meeting. As previously disclosed, solanezumab did not meet the ... of solanezumab initiated in people with mild dementia due ... regulatory submissions for solanezumab for the treatment of mild ...

(Date:12/8/2016)... Pa. , Dec. 8, 2016 Pennsylvania ... Secretary of Drug and Alcohol Programs Gary ... and insomnia medications, known as benzodiazepines, developed with ... "Benzodiazepines are medications that are frequently prescribed ... when they are used with opioid pain medications, ...

(Date:12/9/2016)... ... December 09, 2016 , ... Sober College, ... with the grand opening of the Sober College Robert Pfeifer Memorial Learning Center ... December 2-3, and was attended by an overwhelming amount of alumni, family, colleagues ...

(Date:12/9/2016)... , ... December 09, 2016 , ... "I had a ... inventor from Winchester, Va. "I thought that if the nebulizer had a more child-friendly ... than fearing them." , He developed the patent-pending NEBY to avoid the need to ...

(Date:12/8/2016)... , ... December 08, 2016 , ... ... Franchising Company LLC, announced the first national #QuackGivesBack campaign which supported local ... “This was our first franchise-wide Quack Gives Back initiative, and we’re ...

(Date:12/8/2016)... ... December 08, 2016 , ... With the increasing demand for dental implants, the ... (WIYM) campaign to inform dentists and patients about the safety issues related to dental ... market in the U.S. is projected to reach $6.4 billion in 2018 with more ...